Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Amy L. Burroughs currently holds 120,000 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy L. Burroughs has been a net buyer of DMAC stock. They have purchased $141.6K and sold $0 worth of shares.
Amy L. Burroughs's most recent insider trade was on May 28, 2026, when they sold 120,000 shares at $0.00 per share.
Amy L. Burroughs serves as Executive at DiaMedica Therapeutics Inc. (DMAC). They have executed 7 insider transactions totaling $141.6K over their tenure at the company.
Amy L. Burroughs holds the position of Executive at DiaMedica Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Amy L. Burroughs has shown a buying trading pattern, with $141.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Amy L. Burroughs was on Aug 16, 2021, when they purchased $141.6K worth of DMAC shares. This transaction involved 44,950 shares at $3.15 per share.
Amy L. Burroughs currently owns 120,000 shares of DiaMedica Therapeutics Inc. (DMAC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Amy L. Burroughs's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Amy L. Burroughs has 7 Form 4 filings on record as an insider at DiaMedica Therapeutics Inc..
Set alerts for Amy L. Burroughs and 40,000+ other insiders.